Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

Nonalcoholic fatty liver disease (NAFLD) affects up to 40% of the population in western countries and is one of the most ...

Glycolysis is a central metabolic pathway by which cells obtain energy from sugar. Cancer cells in particular have long been ...

It demonstrates the potential of organ-on-a-chip technology to simulate the human liver's blood vessels, allowing for a better understanding of how immune cells navigate the blood stream and cross ...

Salk scientists link bile acids and immune cell performance in liver cancer, finding that supplementing the bile acid UDCA—already a current treatment for liver disease—and inhibiting bile ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

Editas Medicine (EDIT) announced its three-year strategic priorities, anticipated 2025 key milestones, and new in vivo preclinical proof of ...

Liver-derived MSCs ... Allogeneic therapies, in contrast, use cells taken from other human donors, not the patient themself (the recipient). This means health-care facilities can buy in supplies ...